Co-amilofruse

Co-amilofruse (BAN) is a nonproprietary name used to denote a combination of amiloride and furosemide, which are both diuretics.[1] Co-amilofruse is a treatment for fluid retention (oedema), either in the legs (peripheral edema) or on the lungs (pulmonary oedema). Furosemide is a loop diuretic and is more effective than amiloride, but has a tendency to cause low potassium levels (hypokalaemia); the potassium-sparing effects of amiloride may balance this.

Co-amilofruse
Combination of
AmiloridePotassium-sparing diuretic
FurosemideLoop diuretic
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
Oral
ATC code
Legal status
Legal status
  • UK: POM (Prescription only)
Identifiers
ChemSpider
  • none
 ☒NcheckY (what is this?)  (verify)

FormulationEdit

Two strengths of co-amilofruse are available:

  • 2.5 mg amiloride with 20 mg furosemide, BAN of Co-amilofruse 2.5/20 (brand name Frumil LS)
  • 5 mg amiloride with 40 mg furosemide, BAN of Co-amilofruse 5/4-0 (brand name Frumil)

ReferencesEdit

  1. ^ Hitchings A, Lonsdale D, Burrage D, Baker E (2014). Top 100 drugs : clinical pharmacology and practical prescribing. Edinburgh: Elsevier Health Sciences. p. 113. ISBN 978-0-7020-5515-7.